FI972660A - Piperatsini-2,5-dionijohdannaiset monilääke resistanssi modulaattoreina - Google Patents

Piperatsini-2,5-dionijohdannaiset monilääke resistanssi modulaattoreina Download PDF

Info

Publication number
FI972660A
FI972660A FI972660A FI972660A FI972660A FI 972660 A FI972660 A FI 972660A FI 972660 A FI972660 A FI 972660A FI 972660 A FI972660 A FI 972660A FI 972660 A FI972660 A FI 972660A
Authority
FI
Finland
Prior art keywords
piperazine
multidrug resistance
dione derivatives
resistance modulators
modulators
Prior art date
Application number
FI972660A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972660A0 (fi
Inventor
Philip Anthony Ashworth
Sukhjit Hunjan
Ian Andrew Pretswell
Hamish Ryder
Stephen James Brocchini
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of FI972660A0 publication Critical patent/FI972660A0/fi
Publication of FI972660A publication Critical patent/FI972660A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI972660A 1994-12-23 1997-06-19 Piperatsini-2,5-dionijohdannaiset monilääke resistanssi modulaattoreina FI972660A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426224.3A GB9426224D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds
PCT/GB1995/003027 WO1996020190A1 (en) 1994-12-23 1995-12-22 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance

Publications (2)

Publication Number Publication Date
FI972660A0 FI972660A0 (fi) 1997-06-19
FI972660A true FI972660A (fi) 1997-08-22

Family

ID=10766589

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972660A FI972660A (fi) 1994-12-23 1997-06-19 Piperatsini-2,5-dionijohdannaiset monilääke resistanssi modulaattoreina

Country Status (19)

Country Link
EP (1) EP0799222A1 (zh)
JP (1) JPH10511384A (zh)
CN (1) CN1175253A (zh)
AU (1) AU698828B2 (zh)
BG (1) BG101602A (zh)
BR (1) BR9510410A (zh)
CA (1) CA2207500A1 (zh)
CZ (1) CZ190097A3 (zh)
FI (1) FI972660A (zh)
GB (1) GB9426224D0 (zh)
HU (1) HUT77943A (zh)
IL (1) IL116525A0 (zh)
NO (1) NO972937D0 (zh)
NZ (1) NZ297847A (zh)
PL (1) PL320916A1 (zh)
SK (1) SK83697A3 (zh)
TW (1) TW358094B (zh)
WO (1) WO1996020190A1 (zh)
ZA (1) ZA9510909B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9717576D0 (en) * 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
HUP0001531A3 (en) * 1996-10-18 2000-09-28 Xenova Ltd Slough Anthranilic acid derivatives as multi drug resistance modulators
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
EA200100428A1 (ru) 1998-10-08 2001-10-22 Смитклайн Бичам Плс Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты)
NZ519989A (en) * 2000-01-18 2004-05-28 Nereus Pharmaceuticals Inc Cell division inhibitors and process for producing the same
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
DE60316688T2 (de) 2002-08-02 2008-07-17 Nereus Pharmaceuticals, Inc., San Diego Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
BR112017018954A2 (pt) 2015-03-06 2018-05-15 Beyondspring Pharmaceuticals, Inc. uso de forma mutante de proteína ras e método para tratar câncer
CA2978679A1 (en) 2015-03-06 2016-09-15 Beyondspring Pharmaceuticals, Inc. Method of treating a brain tumor
CN113735834B (zh) 2015-07-13 2023-06-13 大连万春布林医药有限公司 普那布林组合物
IL260933B2 (en) 2016-02-08 2023-04-01 Beyondspring Pharmaceuticals Inc Preparations containing tocorsol or its analogues
KR20190015361A (ko) 2016-06-06 2019-02-13 비욘드스프링 파마수티컬스, 인코포레이티드. 호중구감소증을 줄이는 조성물 및 방법
WO2018129381A1 (en) 2017-01-06 2018-07-12 Beyondspring Pharmaceuticals, Inc. Tubulin binding compounds and therapeutic use thereof
SG11201907023UA (en) 2017-02-01 2019-08-27 Beyondspring Pharmaceuticals Inc Method of reducing neutropenia
KR20200112881A (ko) 2018-01-24 2020-10-05 비욘드스프링 파마수티컬스, 인코포레이티드. 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE152443T1 (de) * 1992-07-10 1997-05-15 Glaxo Lab Sa Anilide-derivate
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
GB9426224D0 (en) 1995-02-22
SK83697A3 (en) 1998-05-06
JPH10511384A (ja) 1998-11-04
IL116525A0 (en) 1996-03-31
FI972660A0 (fi) 1997-06-19
CZ190097A3 (cs) 1998-01-14
EP0799222A1 (en) 1997-10-08
CA2207500A1 (en) 1996-07-04
PL320916A1 (en) 1997-11-10
ZA9510909B (en) 1996-08-30
BG101602A (en) 1998-02-27
WO1996020190A1 (en) 1996-07-04
CN1175253A (zh) 1998-03-04
BR9510410A (pt) 1999-09-08
AU698828B2 (en) 1998-11-05
AU4310096A (en) 1996-07-19
NO972937L (no) 1997-06-23
NZ297847A (en) 1999-04-29
TW358094B (en) 1999-05-11
NO972937D0 (no) 1997-06-23
HUT77943A (hu) 1998-12-28

Similar Documents

Publication Publication Date Title
FI972660A (fi) Piperatsini-2,5-dionijohdannaiset monilääke resistanssi modulaattoreina
NO991563L (no) N-substituerte, azaheterosykliske forbindelser
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
ATE264327T1 (de) Substituierte 6,6-heterobicyclische derivate
DE69809755D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalin derivate
PT922050E (pt) Derivados de 3-descladinose-2,3-anidroeritromicina
NO982124L (no) Kondenserte imidazolderivater som multilegemiddel resistanse modulatorer
DE69628458D1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalceriferol derivate
NL1013652A1 (nl) Piperazinonderivaten.
NO995491D0 (no) Polyolefin inneholdende polyeteraminmodifisert funksjonalisert polyolefin
AU4310196A (en) Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
ES1036800Y (es) Bicicleta plegable.
ITTO940791A0 (it) Composizione adesiva.
DE29606126U1 (de) Angebotsmappe
ES1033728Y (es) Bolsa plegable perfeccionada.
ES1034386Y (es) Calzo plegable perfeccionado.
GB2310854B (en) Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
TR199600665A2 (tr) Asimetrik trifenilendioksazin bilesikleri.
DE29808234U1 (de) Präsentationsmappe, eigens Bewerbungsmappe
ES1037001Y (es) Carpeta perfeccionada.
ES1037110Y (es) Maquina envasadora perfeccionada.
ES1034154Y (es) Carpeta perfeccionada.
GB9815066D0 (en) Piperazine 2, 5-dione derivatives as modulators of multidrug resistance
ES1037927Y (es) Bolsa perfeccionada.